| Mariam Aboukar, DO | |
|
1493 Cambridge St, Cambridge, MA 02139-1099 | |
| (617) 665-1000 | |
| Not Available |
| Full Name | Mariam Aboukar |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 7 Years |
| Location | 1493 Cambridge St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013448620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | NA (Illinois) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 283215 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Medical Center | Peoria, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Human Service Center | 6901896968 | 5 |
News Archive
Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience.
In order to further the mission to simplify diabetes management, Abbott announces a first-of-its-kind mobile app that will enable people with diabetes to access glucose data directly from their FreeStyle Libre sensor, on their smartphones.
Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma, according to data presented at the International Liver Congress 2011.
Novartis have announced that its Board of Directors has decided to launch a new share repurchase program for up to CHF 3 billion following the completion of a program initiated in 2002. The new program was approved by shareholders at the Annual General Meeting (AGM) in February 2004.
Ludwig-Maximilian-Universitaet in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.
› Verified 2 days ago
| Entity Name | Human Service Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881630689 PECOS PAC ID: 6901896968 Enrollment ID: O20040513000449 |
News Archive
Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience.
In order to further the mission to simplify diabetes management, Abbott announces a first-of-its-kind mobile app that will enable people with diabetes to access glucose data directly from their FreeStyle Libre sensor, on their smartphones.
Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma, according to data presented at the International Liver Congress 2011.
Novartis have announced that its Board of Directors has decided to launch a new share repurchase program for up to CHF 3 billion following the completion of a program initiated in 2002. The new program was approved by shareholders at the Annual General Meeting (AGM) in February 2004.
Ludwig-Maximilian-Universitaet in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.
› Verified 2 days ago
| Entity Name | Khalil Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407225709 PECOS PAC ID: 4284056466 Enrollment ID: O20200616002420 |
News Archive
Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience.
In order to further the mission to simplify diabetes management, Abbott announces a first-of-its-kind mobile app that will enable people with diabetes to access glucose data directly from their FreeStyle Libre sensor, on their smartphones.
Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma, according to data presented at the International Liver Congress 2011.
Novartis have announced that its Board of Directors has decided to launch a new share repurchase program for up to CHF 3 billion following the completion of a program initiated in 2002. The new program was approved by shareholders at the Annual General Meeting (AGM) in February 2004.
Ludwig-Maximilian-Universitaet in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mariam Aboukar, DO 1875 W Dempster St, Suite 470, Park Ridge, IL 60068-1186 Ph: () - | Mariam Aboukar, DO 1493 Cambridge St, Cambridge, MA 02139-1099 Ph: (617) 665-1000 |
News Archive
Research by a Barrow Neurological Institute scientist on the thermoregulatory effects of a receptor more commonly studied for its role in pain is the cover story in the Feb. 2 issue of the Journal of Neuroscience.
In order to further the mission to simplify diabetes management, Abbott announces a first-of-its-kind mobile app that will enable people with diabetes to access glucose data directly from their FreeStyle Libre sensor, on their smartphones.
Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma, according to data presented at the International Liver Congress 2011.
Novartis have announced that its Board of Directors has decided to launch a new share repurchase program for up to CHF 3 billion following the completion of a program initiated in 2002. The new program was approved by shareholders at the Annual General Meeting (AGM) in February 2004.
Ludwig-Maximilian-Universitaet in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.
› Verified 2 days ago
Omayra Nieves, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 30 Cambridgepark Dr Apt 6115, Cambridge, MA 02140 Phone: 617-877-5797 | |
Stella J Bae, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 49 Hancock St, Cambridge, MA 02139 Phone: 617-566-1055 | |
Dr. Peter F Wohlauer, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1105 Massachusetts Ave, Suite 2c, Cambridge, MA 02138 Phone: 617-491-2301 | |
Dr. Daniel A Brenner, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6 Bigelow St, Cambridge, MA 02139 Phone: 617-661-1856 | |
Irina Angel, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1611 Cambridge St, Cambridge, MA 02138 Phone: 617-661-5515 Fax: 617-661-5182 | |
George M Dominiak, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 |